Annual Total Liabilities
$2.34 M
-$1.65 M-41.35%
December 31, 2023
Summary
- As of February 8, 2025, ENVB annual total liabilities is $2.34 million, with the most recent change of -$1.65 million (-41.35%) on December 31, 2023.
- During the last 3 years, ENVB annual total liabilities has risen by +$1.66 million (+243.97%).
- ENVB annual total liabilities is now -92.84% below its all-time high of $32.75 million, reached on December 31, 2017.
Performance
ENVB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$839.20 K
+$193.90 K+30.05%
September 30, 2024
Summary
- As of February 8, 2025, ENVB quarterly total liabilities is $839.20 thousand, with the most recent change of +$193.90 thousand (+30.05%) on September 30, 2024.
- Over the past year, ENVB quarterly total liabilities has increased by +$193.90 thousand (+30.05%).
- ENVB quarterly total liabilities is now -97.60% below its all-time high of $34.92 million, reached on September 30, 2017.
Performance
ENVB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ENVB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.4% | +30.1% |
| 3 y3 years | +244.0% | -79.0% |
| 5 y5 years | -87.6% | -93.7% |
ENVB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.9% | at low | -89.2% | +30.1% |
| 5 y | 5-year | -83.7% | +244.0% | -95.0% | +30.1% |
| alltime | all time | -92.8% | >+9999.0% | -97.6% | >+9999.0% |
Enveric Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $839.20 K(+30.0%) |
| Jun 2024 | - | $645.30 K(-72.7%) |
| Mar 2024 | - | $2.37 M(+1.0%) |
| Dec 2023 | $2.34 M(-41.4%) | $2.34 M(-44.0%) |
| Sep 2023 | - | $4.18 M(-15.1%) |
| Jun 2023 | - | $4.93 M(+11.0%) |
| Mar 2023 | - | $4.44 M(+11.1%) |
| Dec 2022 | $4.00 M(-9.5%) | $4.00 M(-44.9%) |
| Sep 2022 | - | $7.25 M(+21.5%) |
| Jun 2022 | - | $5.97 M(-22.9%) |
| Mar 2022 | - | $7.74 M(+75.3%) |
| Dec 2021 | $4.41 M(+547.8%) | $4.41 M(-69.3%) |
| Sep 2021 | - | $14.39 M(+195.1%) |
| Jun 2021 | - | $4.88 M(-28.2%) |
| Mar 2021 | - | $6.79 M(+897.3%) |
| Dec 2020 | $681.30 K(-95.3%) | $681.30 K(-95.4%) |
| Sep 2020 | - | $14.82 M(+1.3%) |
| Jun 2020 | - | $14.63 M(-13.5%) |
| Mar 2020 | - | $16.91 M(+17.6%) |
| Dec 2019 | $14.38 M(-23.8%) | $14.38 M(+7.3%) |
| Sep 2019 | - | $13.41 M(-28.0%) |
| Jun 2019 | - | $18.62 M(-3.8%) |
| Mar 2019 | - | $19.34 M(+2.5%) |
| Dec 2018 | $18.88 M(-42.4%) | $18.88 M(+19.4%) |
| Sep 2018 | - | $15.81 M(-42.0%) |
| Jun 2018 | - | $27.24 M(-5.2%) |
| Mar 2018 | - | $28.75 M(-12.2%) |
| Dec 2017 | $32.75 M(+17.6%) | $32.75 M(-6.2%) |
| Sep 2017 | - | $34.92 M(+3.7%) |
| Jun 2017 | - | $33.67 M(-3.5%) |
| Mar 2017 | - | $34.91 M(+25.4%) |
| Dec 2016 | $27.84 M(+105.1%) | $27.84 M(-16.6%) |
| Sep 2016 | - | $33.37 M(+162.1%) |
| Jun 2016 | - | $12.73 M(-5.2%) |
| Mar 2016 | - | $13.43 M(-33.7%) |
| Dec 2015 | $13.58 M(>+9900.0%) | - |
| Sep 2015 | - | $20.25 M(+117.3%) |
| Jun 2015 | - | $9.32 M(>+9900.0%) |
| Mar 2015 | - | $10.30 K(+14.4%) |
| Dec 2014 | $9000.00(-63.6%) | $9000.00(+291.3%) |
| Sep 2014 | - | $2300.00(+15.0%) |
| Jun 2014 | - | $2000.00(-58.3%) |
| Mar 2014 | - | $4800.00(-80.6%) |
| Dec 2013 | $24.70 K(-3.9%) | $24.70 K(-35.2%) |
| Sep 2013 | - | $38.10 K(+7.9%) |
| Jun 2013 | - | $35.30 K(+17.3%) |
| Mar 2013 | - | $30.10 K(+17.1%) |
| Dec 2012 | $25.70 K(+43.6%) | $25.70 K(+73.6%) |
| Sep 2012 | - | $14.80 K(+48.0%) |
| Jun 2012 | - | $10.00 K(+2.0%) |
| Mar 2012 | - | $9800.00(-45.3%) |
| Dec 2011 | $17.90 K(-64.6%) | $17.90 K(+132.5%) |
| Sep 2011 | - | $7700.00(-89.3%) |
| Jun 2011 | - | $72.30 K(+7.7%) |
| Mar 2011 | - | $67.10 K(+32.6%) |
| Dec 2010 | $50.60 K | $50.60 K(+25.9%) |
| Sep 2010 | - | $40.20 K(+20.0%) |
| Jun 2010 | - | $33.50 K(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $35.50 K(+198.3%) |
| Dec 2009 | $11.90 K(-43.9%) | $11.90 K(-68.4%) |
| Sep 2009 | - | $37.60 K(+3318.2%) |
| Jun 2009 | - | $1100.00(-87.9%) |
| Mar 2009 | - | $9100.00(-57.1%) |
| Dec 2008 | $21.20 K(-55.7%) | $21.20 K(+216.4%) |
| Sep 2008 | - | $6700.00(-6.9%) |
| Jun 2008 | - | $7200.00(-83.0%) |
| Mar 2008 | - | $42.30 K(-11.7%) |
| Dec 2007 | $47.90 K(-45.0%) | $47.90 K(+3.2%) |
| Sep 2007 | - | $46.40 K(-79.7%) |
| Jun 2007 | - | $229.10 K(-30.9%) |
| Mar 2007 | - | $331.70 K(+280.8%) |
| Dec 2006 | $87.10 K(-51.5%) | $87.10 K(-22.6%) |
| Sep 2006 | - | $112.60 K(-2.0%) |
| Jun 2006 | - | $114.90 K(+71.0%) |
| Mar 2006 | - | $67.20 K(-62.6%) |
| Dec 2005 | $179.50 K(-73.1%) | $179.50 K(+8.2%) |
| Sep 2005 | - | $165.90 K(-41.6%) |
| Jun 2005 | - | $284.20 K(-37.7%) |
| Mar 2005 | - | $456.10 K(-31.5%) |
| Dec 2004 | $666.30 K(+166.6%) | $666.30 K(-16.4%) |
| Sep 2004 | - | $796.90 K(+181.2%) |
| Jun 2004 | - | $283.40 K(+21.6%) |
| Mar 2004 | - | $233.00 K(-6.8%) |
| Dec 2003 | $249.90 K(-21.2%) | $249.90 K(-13.9%) |
| Sep 2003 | - | $290.20 K(+6.6%) |
| Jun 2003 | - | $272.30 K(+6.4%) |
| Mar 2003 | - | $256.00 K(-19.2%) |
| Dec 2002 | $317.00 K(-7.2%) | $317.00 K(-8.6%) |
| Sep 2002 | - | $346.70 K(-6.1%) |
| Jun 2002 | - | $369.10 K(+20.2%) |
| Mar 2002 | - | $307.10 K(-10.1%) |
| Dec 2001 | $341.50 K(-57.6%) | $341.50 K(-4.6%) |
| Sep 2001 | - | $358.00 K(-13.9%) |
| Jun 2001 | - | $415.80 K(-40.0%) |
| Mar 2001 | - | $692.60 K(-14.1%) |
| Dec 2000 | $806.30 K(-40.3%) | $806.30 K(-12.6%) |
| Sep 2000 | - | $922.40 K(-3.7%) |
| Jun 2000 | - | $957.70 K(-18.7%) |
| Mar 2000 | - | $1.18 M(-51.9%) |
| Dec 1999 | $1.35 M(-44.8%) | - |
| Dec 1998 | $2.45 M(+49.2%) | $2.45 M(+43.9%) |
| Sep 1998 | - | $1.70 M(+21.4%) |
| Jun 1998 | - | $1.40 M(-26.3%) |
| Mar 1998 | - | $1.90 M(+15.9%) |
| Dec 1997 | $1.64 M(+87.8%) | $1.64 M(+105.0%) |
| Sep 1997 | - | $800.00 K(+33.3%) |
| Jun 1997 | - | $600.00 K(-14.3%) |
| Mar 1997 | - | $700.00 K(-19.8%) |
| Dec 1996 | $873.30 K(+24.8%) | $873.30 K(+45.6%) |
| Sep 1996 | - | $600.00 K(-14.3%) |
| Jun 1996 | - | $700.00 K(+16.7%) |
| Mar 1996 | - | $600.00 K(-14.3%) |
| Dec 1995 | $700.00 K(-22.2%) | $700.00 K(-70.8%) |
| Dec 1994 | $900.00 K(-62.5%) | - |
| Aug 1994 | - | $2.40 M |
| Aug 1994 | $2.40 M | - |
FAQ
- What is Enveric Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Enveric Biosciences?
- What is Enveric Biosciences annual total liabilities year-on-year change?
- What is Enveric Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Enveric Biosciences?
- What is Enveric Biosciences quarterly total liabilities year-on-year change?
What is Enveric Biosciences annual total liabilities?
The current annual total liabilities of ENVB is $2.34 M
What is the all time high annual total liabilities for Enveric Biosciences?
Enveric Biosciences all-time high annual total liabilities is $32.75 M
What is Enveric Biosciences annual total liabilities year-on-year change?
Over the past year, ENVB annual total liabilities has changed by -$1.65 M (-41.35%)
What is Enveric Biosciences quarterly total liabilities?
The current quarterly total liabilities of ENVB is $839.20 K
What is the all time high quarterly total liabilities for Enveric Biosciences?
Enveric Biosciences all-time high quarterly total liabilities is $34.92 M
What is Enveric Biosciences quarterly total liabilities year-on-year change?
Over the past year, ENVB quarterly total liabilities has changed by +$193.90 K (+30.05%)